SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-004242
Filing Date
2022-03-24
Accepted
2022-03-24 11:10:47
Documents
101
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 20-F lvtx-20211231x20f.htm   iXBRL 20-F 3345215
2 EX-2.1 lvtx-20211231xex2d1.htm EX-2.1 88521
3 EX-8.1 lvtx-20211231xex8d1.htm EX-8.1 5289
4 EX-12.1 lvtx-20211231xex12d1.htm EX-12.1 20880
5 EX-12.2 lvtx-20211231xex12d2.htm EX-12.2 20879
6 EX-13.1 lvtx-20211231xex13d1.htm EX-13.1 9640
7 EX-13.2 lvtx-20211231xex13d2.htm EX-13.2 9626
8 EX-15.1 lvtx-20211231xex15d1.htm EX-15.1 3565
9 GRAPHIC lvtx-20211231x20f001.jpg GRAPHIC 5990
10 GRAPHIC lvtx-20211231x20f002.jpg GRAPHIC 44006
11 GRAPHIC lvtx-20211231x20f003.jpg GRAPHIC 8479
12 GRAPHIC lvtx-20211231x20f004.jpg GRAPHIC 37679
  Complete submission text file 0001558370-22-004242.txt   10727094

Data Files

Seq Description Document Type Size
13 EX-101.SCH lvtx-20211231.xsd EX-101.SCH 80849
14 EX-101.CAL lvtx-20211231_cal.xml EX-101.CAL 61707
15 EX-101.DEF lvtx-20211231_def.xml EX-101.DEF 209843
16 EX-101.LAB lvtx-20211231_lab.xml EX-101.LAB 516447
17 EX-101.PRE lvtx-20211231_pre.xml EX-101.PRE 399532
95 EXTRACTED XBRL INSTANCE DOCUMENT lvtx-20211231x20f_htm.xml XML 1893805
Mailing Address YALELAAN 60 UTRECHT P7 3584 CM
Business Address YALELAAN 60 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Filer) CIK: 0001840748 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-40241 | Film No.: 22765365
SIC: 2834 Pharmaceutical Preparations